Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Indian Businesses to Benefit from Bitrix24’s Free Platform and Competitive Pricing Business
  • PCTI-JanMitr organized a Play- ‘Ek Nayi Fauj’ at the auditorium of Deen Dayal Upadhyaya Gorakhpur University Business
  • MatrixBox Slim SS and Midnight Black by Hafele Business
  • Bank of Baroda Introduces Live Video Calling and Live Web Chat facility to enhance customer service Business
  • Abhigyan Foundation felicitates citizens with Indian Excellence Awards 2021 for their contribution towards growth and development Press Release
  • Hrithik Roshan to continue as brand ambassador for Clear Premium Water Business
  • Dr Ravul Jindal Empowers SAARC Doctors with Expertise in Vascular Surgery in Sri Lanka Health
  • 10 Indian influential personalities making their mark in 2023 Business

Martin & Harris Labs reports robust results in FY21, PAT zooms 139% to Rs 177 Cr

Posted on January 15, 2022 By

New Delhi, January 15: Martin & Harris Laboratories, the pharmaceutical arm of Apeejay Group, has announced its results for the financial year ended on 31 March, 2021.

In the financial year 2020-21, Martin & Harris Laboratories clocked a profit after tax (PAT) of Rs 177 crore, a rise of 138.96% against a net profit of Rs 70 crore in the financial year 2019-20.

In the last seven years, the revenue of the company has grown at a CAGR of 30% and from Rs 67 crore to 336 crore, whereas PAT has surged at a CAGR of 61% to Rs 177 crore.

The total income for the FY 2020-21 includes Rs 138 crore from pharma business and Rs 196 crore from investment business. Earnings per share (EPS) of the company zoomed to 443 in FY21 against an EPS of 180 in FY20.

In FY21, Delite Infrastructure an investment arm of Martin and Harris Laboratory has generated EBIT of 160 Crores on capital of 400 Crores, which is 40% return on capital. And, though period and portfolio is large, if we benchmark this with Warren Buffet’s investment company Berkshire Hathaway, same has generated 20% CAGR return in the last 40 years. This shows that investment arm of Martin and Harris Laboratory is generating handsome return to shareholders.

Martin & Harris Laboratories have a couple of manufacturing facilities in Roorkee (Uttarakhand) and Una (Himachal Pradesh) wherein they manufacture some famous medicines like Drotin Plus, Amclox, Venusmin and Tamsin etc which are having high demand in the market. The company is constantly taking steps to modernize and expand its manufacturing units to meet international standards.

Apeejay Group was established in 1910 by Shri Pyare Lal Ji, which today has an annual turnover of more than Rs 2,500 Cr. From starting its journey in Jalandhar to manufacture steel goods for the domestic agriculture industry, today Apeejay Group has ventured into hotels, real estates, constructions, shipping and pharmaceuticals. Later on the legacy of Shri Pyare Lal was being carried out by his sons Surrendra and Stya. And, accordingly, the group was divided into two parts i.e. Apeejay Surrendra and Apeejay Stya Group.

Today, Apeejay Stya Group manages Martin and Harris Laboratory i.e. Pharma Business along with Apeejay Education Society and the Apeejay Stya Universities. Dr Stya Paul’s legacy of excellence is being carried forward by his daughter and only child, Mrs Sushma Paul Berlia, Chairman of the Apeejay Education Society.

Apeejay Surrendra Group business activities are presently oversee by his son and daughters i.e. Priya, Priti and Karan Paul.

Valuation

In the pre IPO market, the shares of Martin & Harris Laboratories are trading at Rs 2900-3000 apiece. With an average EPS of Rs 270 for the last three years, it commands a price to earnings (P/E) ratio little more than 10.75 to 11.11x.

On a standalone basis, the company’s pharma arm generated a net profit of Rs 40 crore in FY 2020-21 with an average EPS of Rs 102 for the last three years, it is trading at a P/E ratio of 28x. Nifty Pharma index is trading at a P/E ratio of 33x, there is ample upside left in the company.

Business Tags:Business

Post navigation

Previous Post: First-of-its-kind clinic launched in Lucknow to cure PCOD hormonal disorder in women
Next Post: IG Drones partners up with the Government of Gujarat at Pre-Vibrant Gujarat Summit

Related Posts

  • WTiCabs Launches, Second Batch of Graduate Trainee Program, Paving the Way for Promising Careers Business
  • Yokohama Announces Women’s Car Rally In Bengaluru Business
  • A Version Of The Art And Science Of Sales Book For Sales Managers Is Now Available In Hindi Worldwide Business
  • Saubhagyaa R Swain, Chairman Vincitore Group ink the pact with Odisha Government for upcoming power plant projects. Business
  • Balu Forge Industries Ltd Enhances Forging Production Capacity with Recent Acquisition Business
  • BoM celebrates 88th Business Commencement Day, Launches slew of Digital products & services Business

Recent Posts

  • Aayush Wellness Launches Brain Fuel Capsules
  • India’s AI Future Begins Here: Scaler School of Technology’s New-Age Engineering Blueprint
  • Protyze Launches HYDRA-X: India’s An Advanced Clear Protein with Electrolytes, Creatine & Glutamine.
  • IMS Ghaziabad (University Courses Campus) and Dainik Jagran Honor Academic Excellence at the ‘Pratibha Samman’ Ceremony
  • Vedic Meet – India’s Leading Problem-Solving App for Online Astrology

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • PallyCon unveils Robust Distributor Watermarking to Fortify Premium Content in the Distribution Phase Business
  • Varmora Granito launches Premium Sanitaryware and Faucets Range Business
  • Band-It 2024: A Glorious Tribute to the Young Talent of India in Music and Performing Arts Entertainment
  • Prabhat Kumar & Neha Malik’s song ‘Apni To Party’ crosses 1 million views on YouTube Entertainment
  • Sudheer Sandra, Psychologist, founder of SUPAR school – Worlds First Digital Parallel School, enters the International Wonder Book of Records Business
  • Dr. Samrat Ray: Championing Skill Development for Economic and Social Empowerment Lifestyle
  • Smriti Silwal Brings A Spark To The Inaugural Ceremony Of Ananta Khushiyaan’s New Shelter Home For Homeless Girl Child Lifestyle
  • 900 Global Delegates from High School, Universities, and Educational Organizations Participate In the 5th Annual IC3 Conference Press Release

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme